logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Early TNBC: capecitabine after standard chemo fails to extend DFS in phase 3 GEICAM-CIBOMA

Exception was nonbasal phenotype, which benefited in subgroup analysis.